We welcome working with you on manuscripts in any area of #braintumor #CancerResearch #cancercare #spinetumors #metastases #pediatricbraintumor #molecularpathology #Neurosurgery #neuroscience of #braincancer & more. neuro.onc.advances@gmail.com.

We have new #articles coming out every week - here are our latest ones published in #NeuroOncology Advances. To access these, click here and scroll to the bottom of the page:

We are very pleased to announce that the new #ImpactFactor for #NeuroOncology Advances is now 4.1 (up from 3.7 the previous year)!

The initial response to induction #chemotherapy is an important prognostic factor in primary central nervous system lymphoma (#PCNSL) - this was the finding of some recent research. Read the full article here:

Solitary fibrous tumors/#hemangiopericytoma are rare central #CNS exhibiting high recurrence rates and the ability to metastasize. This study evaluated #SFT prognosis and survival outcomes, focusing on the 2021 WHO classification. #LaySummary & article:

Looking for in-depth #metrics on your published #articles? . #NeuroOncology Advances provides a range of third-party metrics, giving you insight into the performance, reach, and impact at title level or for individual #research outputs. Find out more:

Although small subsets of #Glioblastoma patients survive longer than 3 years, there is little evidence regarding the prognostic factors of #GBM. Therefore, this study conducted a thorough characterization of GBM in the United States. Read full article:

Does the #resection location have an impact on #depressive symptoms following #glioma surgery?. Read the lay summary or full article in our latest issue:

We are proud to have a very easy and straightforward article submission process, with ease of use and quick submission to decision. Learn more here: #NeuroOncologyAdvances #NeuroOncology #oncology #CancerResearch

This new study in NOA is the first study to describe the framework and patient profile of a #multidisciplinary #AYA #NeuroOncology clinic in a quaternary #CancerCenter in #Canada. Read about it now:

Integrating early #PalliativeCare in #glioblastoma management is feasible - this was the conclusion of a recently conducted study. Read the full clinical investigation in our latest issue:

Given the poor predictive value of #GeneticBiomarkers in #glioblastoma, this study conducted a prospective #ClinicalTrial to investigate the novel approach of cultivated patient-derived tumor cells (PDCs) for ex vivo drug screening. Read more:

Interested in staying up-to-date on #NeuroOncology #Pediatrics?. Read our new @OUPAcademic #OpenAccess sister journal that includes basic & translational #research, #ClinicalTrials, & high-quality studies from around the globe!. @EANOassociation @NeuroOnc

RT @NeuroOnc: Join us for a free informational webinar for medical students, graduate students, residents, fellows or postdocs to learn abo….

These unprecedented research findings were that blood group O status in conjunction with MGMT promoter #methylation (including weak methylation) is an independent favorable prognostic marker in GBM IDH-wt patients receiving standardized #radiochemotherapy:

RT @NeuroOnc: 🚨 LAST CALL 🚨.Today’s the day! Abstract submissions for WFNOS/SNO 2025 close TONIGHT at 11:59 PM ET. 🏝️ Join us in Honolulu,….

In publishing with #NeuroOncology Advances, you get the benefit of having your work indexed and on the #OxfordAcademic platform. Learn more about our #submission process here:

Read “Adverse #neurologic events of immune checkpoint inhibitor monotherapy vs. combination therapy for #melanoma” in our latest edition of #NeuroOncology Advances! .

How can 18F-fluorothymidine (18F-FLT) PET combined with contrast-enhanced #MRI and blood #metabolomics contribute to evaluate prognosis and treatment response for patients with #glioblastoma?. Read about the investigation in our latest issue:

What were people reading in May? . Here’s our top three #articles from the past month! . Click here and scroll down to read them:

Approximately 8.94%–44.44% of nonenhancing adult-type #DiffuseGliomas are identified as #glioblastomas. The purpose of this study was to develop a nomogram that can predict glioblastomas from nonenhancing adult-type diffuse #gliomas.